TrialLancet (London, England)2016

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.

Gérard Zalcman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.